Cleveland Clinic study finds platelets may drive glioblastoma progression
New research published in Cancer Cell reveals that glioblastoma patients have more active platelets, which are blood clotting cells that also communicate with other cells and influence immune activity. The findings suggest platelets may play an unexpected role in the progression of this aggressive brain cancer.
